6875.TWO
Price:
$53.6
Market Cap:
$6.92B
Pharmosa Biopharm Inc., a biotechnology company, focuses on developing drugs in Taiwan. It is developing L606, an inhalation/device combination for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; and L608, an inhalation/device combination for the treatment of pulmonary vascular disease. The company was formerly known as Pharmosa Limited and changed its name to Pharmosa Biopharm Inc. in October 2016. Pharmosa Biopharm Inc. was founded in 2000 and is headquartered in Taipei City, Taiwan.
Industry
Biotechnology
IPO Date
2022-02-22
Stock Exchange
TWO
Ticker
6875.TWO
According to Pharmosa Biopharm Inc.’s latest financial reports and current stock price. The company's current ROE is -15.24%. This represents a change of 286.23% compared to the average of -3.95% of the last 4 quarters.
The mean historical ROE of Pharmosa Biopharm Inc. over the last ten years is -22.65%. The current -15.24% ROE has changed -32.70% with respect to the historical average. Over the past ten years (40 quarters), 6875.TWO's ROE was at its highest in in the September 2023 quarter at 18.77%. The ROE was at its lowest in in the June 2023 quarter at -10.58%.
Average
-22.65%
Median
-21.81%
Minimum
-48.26%
Maximum
0.74%
Discovering the peaks and valleys of Pharmosa Biopharm Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 7.79%
Maximum Annual ROE = 0.74%
Minimum Annual Increase = -Infinity%
Minimum Annual ROE = -48.26%
| Year | ROE | Change |
|---|---|---|
| 2024 | -8.60% | -1256.96% |
| 2023 | 0.74% | -102.12% |
| 2022 | -35.02% | -27.45% |
| 2021 | -48.26% | 7.79% |
| 2020 | -44.77% | -Infinity% |
The current ROE of Pharmosa Biopharm Inc. (6875.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-14.29%
5-year avg
-27.18%
10-year avg
-22.65%
Pharmosa Biopharm Inc.’s ROE is greater than TaiGen Biopharmaceuticals Holdings Limited (-22.99%), greater than Mycenax Biotech Inc. (-25.50%), greater than OBI Pharma, Inc. (-79.60%), greater than CHO Pharma, Inc. (-8.57%), less than Sinphar Pharmaceutical Co.,Ltd. (9.51%), greater than Adimmune Corporation (-4.48%), greater than BioGend Therapeutics Co., Ltd. (-15.67%), less than Panion & Bf Biotech Inc. (6.83%), less than Savior Lifetec Corporation (12.67%), less than Locus Cell Co., Ltd. (0%),
| Company | ROE | Market cap |
|---|---|---|
| -22.99% | $7.94B | |
| -25.50% | $6.76B | |
| -79.60% | $7.59B | |
| -8.57% | $6.42B | |
| 9.51% | $5.83B | |
| -4.48% | $8.14B | |
| -15.67% | $4.75B | |
| 6.83% | $5.72B | |
| 12.67% | $5.65B | |
| 0% | $5.77B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharmosa Biopharm Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pharmosa Biopharm Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Pharmosa Biopharm Inc.'s ROE?
How is the ROE calculated for Pharmosa Biopharm Inc. (6875.TWO)?
What is the highest ROE for Pharmosa Biopharm Inc. (6875.TWO)?
What is the 3-year average ROE for Pharmosa Biopharm Inc. (6875.TWO)?
What is the 5-year average ROE for Pharmosa Biopharm Inc. (6875.TWO)?
How does the current ROE for Pharmosa Biopharm Inc. (6875.TWO) compare to its historical average?